MYLAN-MONTELUKAST
MYLAN PHARMACEUTICALS ULC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MYLAN-MONTELUKAST discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MYLAN-MONTELUKAST 4MG has been permanently discontinued (last updated September 8, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MYLAN-MONTELUKAST not available?
The reason the manufacturer reported: Business reasons.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
RATIO-MONTELUKAST
TEVA CANADA LIMITED
DOM-MONTELUKAST
DOMINION PHARMACAL
Other Products
SINGULAIR
ORGANON CANADA INC.
BIO-MONTELUKAST
BIOMED PHARMA
MAR-MONTELUKAST
MARCAN PHARMACEUTICALS INC
MINT-MONTELUKAST
MINT PHARMACEUTICALS INC
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02380749
Strength
4MG
Dosage Form
TABLET (CHEWABLE)
Route
ORAL
Compare with another product →
Shortage History
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
12.5MG · DIN 02554631
100MG · DIN 02247244
25MG · DIN 02247243